Key players in drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US). Rising R&D expenditure and increasing focus on drug discovery are the major factors driving the adoption of discovery informatics solutions. North America is expected to account for the largest share of the drug discovery informatics market in 2017
- Advertising -
Download the Brochure of Drug Discovery Informatics Market spread across 115 Pages, Profiling 15 Companies and Supported with 63 Tables and 24 Figures is now available at www.reportsnreports.com/contacts/r…aspx?name=1262142 .
Global drug discovery informatics market is projected to reach USD 2.84 Billion in 2022 from USD 1.50 Billion in 2016, at CAGR of 11.2%. Base year considered for study is 2016, and the forecast for market size is provided for period between 2017 and 2022.
In current market scenario, there is a growing demand for discovery informatics solutions.
- Advertising -
- Providers drug discovery informatics solution
- Pharmaceutical companies
- Academic institutes
- Biotechnology companies
- Research institutes
- Government associations
- Contract research organizations (CROs)
Drug discovery informatics market is divided into sequencing & target data analysis, docking, molecular modeling, libraries & database preparation, & other functions. In 2017, the sequencing and target data analysis segment is expected to account for largest share of drug discovery informatics market.
Click here for more information on this research report now at www.reportsnreports.com/contacts/i…aspx?name=1262142 .
Growth in drug discovery informatics market is mainly driven by factors such as rising R&D expenditure across the globe, increasing focus on drug delivery, and the need to control drug discovery and development costs. Impending patent expiries and the growing biotechnology industry are also expected to provide a wide range of growth opportunities for players in the market.
Drug Discovery Informatics Market, By Function
2 Sequencing & Target Data Analysis
4 Molecular Modelling
5 Libraries & Database Preparation
Drug Discovery Informatics Market, By End User
2 Pharmaceutical and Biotechnology Companies
3 Contract Research Organizations (CROS)
The drug discovery informatics market in this report is segmented by function, solution, end user, and region. The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the drug discovery informatics market.
Click now for more Details, Queries, Other Information on this study “Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022” report @ www.reportsnreports.com/purchase.aspx?name=1262142 .
North America is expected to account for the largest share of the global drug discovery informatics market. Asia Pacific is expected to register the highest growth rate from 2017 to 2022.
This can be attributed to the fastest-growing APAC pharmaceutical market in the world, the availability of many qualified researchers, and the low cost of human resources and manufacturing.
2 Ranking of Players, 2016
3 Competitive Scenario
4 Collaborations, Partnerships, Agreements, & Acquisitions
6 Product Launches & Enhancements
The largest share of this segment is attributed to the fast and efficient management of data generated throughout the drug discovery process using discovery informatics software solutions.